Candel Therapeutics (CADL) Assets Average: 2021-2023
Historic Assets Average for Candel Therapeutics (CADL) over the last 2 years, with Sep 2023 value amounting to $54.4 million.
- Candel Therapeutics' Assets Average fell 39.00% to $54.4 million in Q3 2023 from the same period last year, while for Sep 2023 it was $54.4 million, marking a year-over-year decrease of 39.00%. This contributed to the annual value of $83.4 million for FY2022, which is 30.91% up from last year.
- According to the latest figures from Q3 2023, Candel Therapeutics' Assets Average is $54.4 million, which was down 13.64% from $63.0 million recorded in Q2 2023.
- Candel Therapeutics' Assets Average's 5-year high stood at $97.4 million during Q2 2022, with a 5-year trough of $54.4 million in Q3 2023.
- Over the past 3 years, Candel Therapeutics' median Assets Average value was $81.3 million (recorded in 2022), while the average stood at $78.8 million.
- In the last 5 years, Candel Therapeutics' Assets Average spiked by 40.73% in 2022 and then slumped by 39.00% in 2023.
- Quarterly analysis of 3 years shows Candel Therapeutics' Assets Average stood at $92.6 million in 2021, then decreased by 12.13% to $81.3 million in 2022, then crashed by 39.00% to $54.4 million in 2023.
- Its last three reported values are $54.4 million in Q3 2023, $63.0 million for Q2 2023, and $72.5 million during Q1 2023.